Trade of the BUY TECH · April McClain Delaney
Bio-Techne Corp - Common Stock (TECH)
Looks like ordinary portfolio activity
| Inside their committee's jurisdiction |
|
0/32 |
| Isolated decision, not a bulk rebalance |
|
18/22 |
|
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
|
|
6/10 |
|
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
|
|
8/8 |
| Member's own account |
|
0/8 |
| Committee chair or ranking member |
|
0/8 |
|
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
|
|
0/6 |
| Position size |
|
0/3 |
| Leveraged instrument (option) |
|
0/3 |
A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.
It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.
The filing it came from
2nd member to buy this in 60 days Also bought by Rob Bresnahan in the 60 days before this filing became public.
filed in 23 days Within the 30-day notification window.
How this position ended
| Sold | Held | Return | vs S&P | |
|---|---|---|---|---|
| 26 May 2025 | 47 d | -13.3% | -18.9% | part of the holding |
Closed by the member. What the member did afterwards, for context. The strategy does not act on it: exiting when members disclose selling cost 6.50 points against holding the full twelve months.
Not in the strategy. Either this purchase falls outside the member's committee jurisdiction, or the security has no usable price history to trade against.
This filing disclosed 21 transactions in total, of which 5 share this trade date (09 Apr 2025).
Filed 02 May 2025 · source PDF
Price
52-week range $43.22 – $72.29. The marker is the entry: the first market open after this filing became public.
Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science …
| Sector | Healthcare |
| Industry | Biotechnology |
| Analyst range | $50 – $73 |
| Employees | 3,000 |
| Instrument | ST |
| Jurisdiction tags | healthcarepharma |
Outside this member's committee jurisdiction (aerospace, agriculture, commodities, technology).
Expressing this with options
An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.
Loading chain…
Outcome
| Held | This trade | S&P 500 | Alpha |
|---|---|---|---|
| 1m | -1.1% | +5.9% | -7.0% |
| 3m | +8.9% | +12.5% | -3.7% |
| 6m | +21.7% | +22.2% | -0.5% |
| 12m 1yr | +12.9% | +30.1% | -17.2% |
| now 15.2 mo | +44.2% | +39.0% | +5.1% |
| 18m | — | — | — |
| 24m | — | — | — |
| 36m | — | — | — |
| 48m | — | — | — |
| 60m 5yr | — | — | — |
Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. The last 5 rows are blank because those windows have not closed yet: this trade was entered 05 May 2025, so anything longer than that is still running.
Other congressional trades in TECH
| Grade | Date | Member | Side | Amount |
|---|---|---|---|---|
| D | 08 Apr 2026 | April McClain Delaney | sale | $1,001 - $15,000 |
| D | 26 Mar 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 24 Feb 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 28 Jan 2026 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 05 Dec 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 02 Dec 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 22 Oct 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 01 Aug 2025 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| D | 26 May 2025 | April McClain Delaney | sale partial | $1,001 - $15,000 |
| E | 29 Apr 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 08 Apr 2025 | Rob Bresnahan | sale | $1,001 - $15,000 |
| E | 01 Apr 2025 | Julie Johnson | sale | $1,001 - $15,000 |
| E | 25 Feb 2025 | Rob Bresnahan | purchase | $1,001 - $15,000 |
| C | 13 Oct 2020 | Greg Gianforte | sale partial | $1,001 - $15,000 |